Genetic testing revealed both had the BRCA gene – one that puts someone at higher risk of developing breast and ovarian ...

From detecting early disease to guiding treatment plans, clinicians are finding ctDNA testing increasingly important.

Genetic testing, which has expanded in recent years with advances in technology and the development of consumer products, is ...

Advanced prostate cancer is cancer that has spread beyond the prostate to distant parts of the body. It is also called ...

Mainz Biomed has announced a partnership with Quest Diagnostics to support the commercialisation of its NextGen colorectal ...

Bobbi Conner talks with MUSC's Dr. Tucker Marrison about cancer screening recommendations for adults, with an update about ...

Indications for and implications of germline genetic testing (GGT) in patients with prostate cancer have expanded over the past decade, particularly related to precision therapies and management. GGT ...

Quest to Support Mainz Biomed’s ReconAAsense FDA Study and Has Option to Commercialize Test Kit Assuming FDA ApprovalBERKELEY ...

(RTTNews) - Mainz Biomed N.V. (MYNZ), Thursday announced a collaboration with Quest Diagnostics Inc. (DGX) to commercialize the former's NextGen screening test for colorectal cancer, called ColoAlert ...

Thirty new medical services are now available to patients as part of the National Health Insurance scheme, including genetic ...

Colon cancer screening is only effective if you complete the test. With 53,000 Americans expected to die from colon cancer in ...

One’s biological age, which measures the body’s physiological state, may help predict who is at risk for developing colon ...